首页> 外文期刊>Balkan Medical Journal >Histocompatibility Testing for Organ Transplantation Purposes in Albania: A Single Center Experience
【24h】

Histocompatibility Testing for Organ Transplantation Purposes in Albania: A Single Center Experience

机译:阿尔巴尼亚器官移植目的组织相容性测试:单一中心经验

获取原文
           

摘要

Background: Histocompatibility testing (HT) which includes donor-recipient human leukocyte antigen (HLA) matching, cross-match testing (XMT) and anti-HLA antibody searching are crucial examinations in solid organ transplantation aiming to avoid the hyperacute graft rejection and also to predict the immunological outcome of the graft. Aims: The aim of this study was to analyse the tissue typing data collected at the Laboratory of Immunology and Histocompatibility of the University Hospital Center of Tirana, Albania, in order to define those actions that should be taken for improvements in the situation of kidney transplantation in Albania. Study Design: Descriptive study. Methods: The donor/recipient cross-match testing was performed through a standard complement-dependent cytotoxicity (CDC) assay using separated donor T and B cells that were tested in parallel with the recipient serum sample. All recipient sera were screened for anti-Class I and anti-Class II HLA antibodies using a bead based Luminex anti-HLA antibody screening test. In the case of detected positivity, an allele-specific anti-HLA antibody determination was conducted with the respective Luminex anti-Class I and Class II HLA antibody determination kits. Results: A total of 174 recipients and 202 donors were typed for the purpose of living donor kidney transplantation at our laboratory between January 2006 and December 2012. The mean age and female gender proportion of patients were 34.9 years and 34.5%, respectively, and 48.0 years and 65.3% for the donors, respectively. Here, 25.9% of the patients reported a positive complement-dependent cytotoxicity cross-match test and/or a positive anti-HLA antibody testing result. Eighteen patients that were negative for the complement-dependent cytotoxicity cross-match test were positive for anti-HLA antibodies. Conclusion: The predominant causes of end-stage renal disease (ESRD) in our patient population are chronic pyelonephritis and glomerulonephritis. The female gender is significantly more frequent among donors, which emphasises the need for more gender equity as far as the altruistic willingness for organ donation is concerned. The significant number of patients with Luminex anti-HLA antibody positivity combined with complement-dependent cytotoxicity cross-match negative results underlines the necessity of using additional methods like cell-based flow cytometry or bead-based Luminex anti-HLA antibody assays for the detection of anti-donor-specific antibodies. We also suggest that the number of kidney transplantations in Albania needs to be increased significantly by expanding it with paired exchange living donation and also by implementing an efficient deceased donor kidney transplantation program.
机译:背景:组织相容性测试(HT)包括供体-受体人类白细胞抗原(HLA)匹配,交叉匹配测试(XMT)和抗HLA抗体搜索,是实体器官移植中的关键检查,目的是避免超急性移植物排斥,并且预测移植物的免疫结果。目的:本研究的目的是分析在阿尔巴尼亚地拉那大学医院中心免疫学和组织相容性实验室收集的组织类型数据,以便确定为改善肾脏移植情况应采取的措施在阿尔巴尼亚。研究设计:描述性研究。方法:使用标准的依赖补体的细胞毒性(CDC)分析方法进行供体/受体交叉匹配测试,使用分离的供体T细胞和B细胞与接受者血清样品平行进行测试。使用基于微珠的Luminex抗HLA抗体筛选测试对所有受体血清进行抗I和抗II类HLA抗体筛选。在检测到阳性的情况下,分别使用Luminex抗I类和II类HLA抗体测定试剂盒进行等位基因特异性抗HLA抗体测定。结果:2006年1月至2012年12月间,在我们的实验室共为活体供体肾移植目的输入了174位接受者和202位供者。患者的平均年龄分别为34.9岁和34.5%,女性为48.0。年和捐助者的65.3%。在此,25.9%的患者报告了阳性的补体依赖性细胞毒性交叉匹配试验和/或阳性的抗HLA抗体试验结果。补体依赖性细胞毒性交叉匹配试验阴性的18名患者的抗HLA抗体阳性。结论:在我们的患者人群中,终末期肾脏疾病(ESRD)的主要原因是慢性肾盂肾炎和肾小球肾炎。在捐助者中,女性的性别明显更为频繁,这强调了就器官捐献的利他意愿而言,需要更多的性别平等。大量Luminex抗HLA抗体阳性并伴有补体依赖性细胞毒性交叉匹配阴性结果的患者强调了必须使用其他方法,如基于细胞的流式细胞仪或基于珠粒的Luminex抗HLA抗体检测来检测抗供体特异性抗体。我们还建议,阿尔巴尼亚的肾脏移植数量需要通过成对的配对活体捐赠扩大,以及通过实施有效的已故死者肾脏移植计划来显着增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号